Sartorius AG
SRT
Κατάταξη σε μετοχές
#1186
Sartorius AG, founded in Göttingen, Germany in 1870, is a global supplier of... Sartorius AG, founded in Göttingen, Germany in 1870, is a global supplier of advanced bioprocess solutions, laboratory products, and associated services. The company's diverse portfolio encompasses several critical areas: For biosensing and detection, it provides biosensors, compliance instruments, system software, label-free detection technologies, and SPR systems. In cell analysis, Sartorius offers live-cell analysis platforms, flow cytometry systems, and specialized cell analysis reagents and consumables. Its media and reagent segment includes a wide array of formulations for antibody and recombinant protein production, viral vaccines, regenerative medicine, and stem cell cultivation, along with downstream buffers, microcarriers, strong acids, bases, alcohols, and detergents. The company manufactures various bioreactor systems, from multi-parallel and benchtop units to single-use, stainless steel, cell culture, and microbial bioreactors, all supported by dedicated software applications. Its extensive filtration product line features membranes, blotting products, filter papers, and glass and quartz microfibre products, alongside a comprehensive range of filtration devices for ultrafiltration, sterile filtration, harvesting, analytical and diagnostic sample preparation, particle analysis, pharmaceutical applications, protein/DNA concentration, venting, clarification, and membrane chromatography. Sartorius also delivers solutions for process filtration, process chromatography, fluid management, and cutting-edge process analytical technology with data analytics. Complementary laboratory equipment includes industrial microbiology systems, water purification units, precision weighing and pipetting/dispensing systems, OEM components, and centrifuges. Beyond its products, Sartorius provides essential services such as bioprocess development and engineering, protein expression system optimization, media and process development, comprehensive testing, instrument support, and validation. These offerings primarily serve the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industrial sectors across the globe.
Τιμή μετοχής
$248.50
Κεφαλαιοποίηση
$19.67B
Αλλαγή (1 ημέρα)
1.95%
Αλλαγή (1 έτος)
17.52%
Χώρα
DE
Εμπόριο Sartorius AG (SRT)
Κατηγορία
Healthcare
Κεφαλαιοποίηση αγοράς του Sartorius AG(SRT)
Κεφαλαιοποίηση: $19.67B
Μέχρι το October 2026, η Sartorius AG έχει χρηματιστηριακή αξία $19.67B. Αυτό καθιστά τη Sartorius AG την 1186th πιο πολύτιμη εταιρεία στον κόσμο βάσει της κεφαλαιοποίησης σύμφωνα με τα δεδομένα μας. Η χρηματιστηριακή κεφαλαιοποίηση είναι η συνολική αγοραία αξία των μετοχών μιας εισηγμένης εταιρείας και χρησιμοποιείται συνήθως για να προσδιοριστεί η αξία μιας εταιρείας.
Ιστορικό κεφαλαιοποίησης αγοράς της Sartorius AG από 2003 έως 2026
SRT σε σύγκριση με τα 5 πιο δημοφιλή stocks
| Η τιμή για SRT | Το περιουσιακό στοιχείο B | Η κεφαλαιοποίηση αγοράς του B | Αποτελέσματα | |
|---|---|---|---|---|
$74,827.93
$16.84B
|
$5.167T | +30,584.79% | ||
|
$72,622.92
$16.84B
|
$5.015T | +29,680.58% | ||
|
$59,496.97
$16.84B
|
$4.108T | +24,298.00% | ||
|
$56,506.51
$16.84B
|
$3.902T | +23,071.70% | ||
|
$38,948.11
$16.84B
|
$2.689T | +15,871.50% |
